WGS (GeneDx Holdings) Net Interest Income: $-3.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WGS GeneDx Holdings Corp WGS
66 GF Score
Price $94.64
GF Value $74.09
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is GeneDx Holdings Net Interest Income?

GeneDx Holdings WGS +5.46% 66 Net Interest Income is $-3.0 Mil as of Jun. 2026. GuruFocus rates WGS with a GF Score™ of 66/100 and a GF Value™ of $74.09 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. GeneDx Holdings's net interest income for the three months ended in Jun. 2026 was $-1.2 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2026 was $-3.0 Mil.

GeneDx Holdings Net Interest Income Related Terms

GeneDx Holdings Net Interest Income Historical Data

* Premium members only.

The historical data trend for GeneDx Holdings's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GeneDx Holdings Net Interest Income Chart

GeneDx Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Interest Income
Get a 7-Day Free Trial -2.76 -0.67 1.11 -3.03 -2.54

GeneDx Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.82 -0.56 -0.52 -0.72 -1.19
WGS
66GF Score
GeneDx Holdings Corp WGS
Net Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GeneDx Holdings Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Interest Income →
What does a Net Interest Income of $-3.0 Mil mean?
GeneDx Holdings (WGS) has a Net Interest Income of $-3.0 Mil as of Jun. 2026.
Is GeneDx Holdings' Net Interest Income too high?
GeneDx Holdings' current Net Interest Income is $-3.0 Mil. Overall, GeneDx Holdings has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GeneDx Holdings' Net Interest Income compare to CDNA and NEO?
GeneDx Holdings' Net Interest Income of $-3.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Interest Income for a Medical Diagnostics & Research company?
A good Net Interest Income depends on the Medical Diagnostics & Research industry context. However, Net Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Interest Income mean?
A high Net Interest Income can signal that a stock is expensive relative to its fundamentals. GeneDx Holdings's current Net Interest Income is $-3.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GeneDx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GeneDx Holdings (WGS) is currently considered Modestly Overvalued. The stock's GF Value™ is $74.09, compared to a current price of $94.64 — trading 27.7% above its estimated fair value. The current Net Interest Income is $-3.0 Mil. GeneDx Holdings' overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Interest Income calculated?
Net Interest Income is calculated from a company's financial statements. For GeneDx Holdings (WGS), the current Net Interest Income is $-3.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GeneDx Holdings (WGS) Overvalued in 2026?

Based on GuruFocus' analysis, GeneDx Holdings stock appears to be overvalued. The current stock price of $94.64 is trading 27.7% above its estimated GF Value™ of $74.09. GuruFocus considers GeneDx Holdings to be Modestly Overvalued.

Key valuation signals for WGS:

  • Net Interest Income: $-3.0 Mil
  • GF Value™: $74.09 vs. price of $94.64 (27.7% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the WGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GeneDx Holdings Business Description

Address 333 Ludlow Street, North Tower, 6th Floor, Stamford, CT, USA, 06902
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
66GF Score

Get the complete analysis for WGS

Net Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$94.64
Price
$74.09
GF Value